On a day when broader indices disappointed investors Dr Reddy's provided reasons to cheer. For the quarter ending March 2015, Dr Reddy's (DRL) reported healthy growth in its generics business across geographies. While Russia and CIS faltered, it was ... Business Standard India, 1 week ago
Dr Reddys: Good show across geographies - Smart Investor, 1 week ago
A shift in focus and deepening reach into the US and the EU has propelled the stock price of Aurobindo Pharma to an all-time high Appearances can be deceptive and so can a name. One would expect a pharmaceutical company originating from ...Outlookbusiness.com, 1 month ago
NEW DELHI: The father-son duo of Shanti Bhushan and Prashant Bhushan on Friday made a high-voltage corruption charge against a former Supreme Court judge and his advocate son while repeatedly pleading with the SC to order registration of an FIR. ...Times of India, 1 month ago
Aurobindo Pharma after correcting about 20% from Rs 1,264 in February has pared a large part of the loss, closing at Rs 1,221 on Tuesday. The correction was due to some disappointment on the margin front in the December'14 quarter, US FDA ...Business Standard India, 2 months ago
on your WebpageAdd Widget >Get your members hooked!